Skip to main content
. 2016 Mar 28;8(9):439–445. doi: 10.4254/wjh.v8.i9.439

Table 1.

Clinical outcomes of portal vein embolization for hepatocellular carcinoma

Ref. Year Technique No. of patients Morbidity (%) Mortality (%) 5-yr disease-free survival (%) 5-yr overall survival (%)
Azoulay et al[11] 2000 PVE 10 55 0 21 44
Tanaka et al[12] 2000 PVE 33 - 3 33 50
Wakabayashi et al[13] 2001 PVE 26 - 11.5 40 46
Sugawara et al[14] 2002 PVE 66 - 0 37.9 58.9
Aoki et al[15] 2004 TACE + PVE 24 24 0 47 56
Ogata et al[16] 2006 TACE + PVE 18 39 - 37 -
PVE 18 56 - 19 -
Seo et al[17] 2007 PVE 32 19 0 37 72
Palavecino et al[18] 2009 PVE 21 24 0 56 72

PVE: Portal vein embolization; TACE: Transcatheter arterial chemoembolization.